To determine whether the infection-dependent macrophage recruitment can also be modulated pharmacologically, we tested a chemical inhibitor of human CXCR3, NBI74330 (Scholten et al., 2014), which binds with high affinity to a pocket formed by the transmembrane domains of CXCR3. The gene discussed is CXCR3; the disease is infection.